Five9 Inc
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Five9, Inc. | |||
| Date: | February 21, 2024 | By: | /s/ Michael Burkland |
|---|---|---|---|
| Michael Burkland | |||
| Chief Executive Officer | |||
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS that each individual whose signature appears below constitutes and appoints Michael Burkland and Barry Zwarenstein, and each of them, severally, as his or her true and lawful attorneys-in-fact and agents with the power to act, with or without the other, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in his or her capacity as a director or officer or both, as the case may be, of the Company, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that each of said attorneys-in-fact and agents, or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Michael Burkland | Chief Executive Officer, Director | February 21, 2024 |
| Michael Burkland | (Principal Executive Officer) | |
| /s/ Barry Zwarenstein | Chief Financial Officer | February 21, 2024 |
| Barry Zwarenstein | (Principal Financial Officer) | |
| /s/ Leena Mansharamani | Chief Accounting Officer | February 21, 2024 |
| Leena Mansharamani | (Principal Accounting Officer) | |
| /s/ Jack Acosta | Director | February 21, 2024 |
| Jack Acosta | ||
| /s/ Susan Barsamian | Director | February 21, 2024 |
| Susan Barsamian | ||
| /s/ Michael Burdiek | Director | February 21, 2024 |
| Michael Burdiek | ||
| /s/ David DeWalt | Director | February 21, 2024 |
| David DeWalt | ||
| /s/ Julie Iskow | Director | February 21, 2024 |
| Julie Iskow | ||
| /s/ Jonathan Mariner | Director | February 21, 2024 |
| Jonathan Mariner | ||
| /s/ David Welsh | Director; Lead Independent Director | February 21, 2024 |
| David Welsh | ||
| /s/ Robert Zollars | Director | February 21, 2024 |
| Robert Zollars | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.